Tag Archives: GlaxoSmithkline Consumer Nigeria plc

GSK weighs selling Horlicks

June 18, 2018   Editor   No comments

Global food and beverage giants are scrambling to outbid each other for GlaxoSmithKline’s Horlick health nutrition business amid a review announced by the UK-based company, including options to sell some nutrition brands such as Horlicks.

Coca-Cola, Nestle and Kraft Heinz are said to be among the companies bidding for the 145 year old brand, with Coca-Cola said to be the front runner with a £3bn (US$4bn) offer.

According to a report by Reuters in March, the most enticing asset up for sale is GSK’s 72.5% stake in its Indian subsidiary GlaxoSmithKline Consumer Healthcare. The sources said the stake was worth $3.1 billion at current market prices but GSK wanted a premium in any sale.

Read More

CBN allocates manufacturers $660m FX to ease pressure

November 21, 2016   Editor   No comments

The Central Bank of Nigeria (CBN), said it has allocated 1,342 manufacturing and trading firms foreign exchange through its recent intervention.

The apex bank said it sold a total of $660m to the firms through FX forwards to their respective banks for onward sales to the firms.

Read More

GSK Consumer Nigeria earnings sink amid FX loss

November 02, 2016   Editor   No comments

GlaxoSmithKline Consumer Nigeria Plc (“GSK Consumer Nigeria Plc”) on Friday reported a net loss of N4bn for the 9-months ending 30th September 2016.

The company which in October finalized the sale of its drinks business (Lucozade and Ribena) including bottling and distribution to Suntory Beverage and Food Nigeria Limited cited unrealized foreign exchange loss of N6.5bn caused by the impact of Naira devaluation for its poor performance.

Read More

GSK Consumer Nigeria completes sale of drinks business to Suntory

October 01, 2016   Editor   2 Comments

GlaxoSmithKline Consumer Nigeria Plc (“GSK Consumer Nigeria Plc”) announced on Friday, 30 September that it had completed the divestment of its drinks business including bottling and distribution to Suntory Beverage & Food Nigeria Limited.

The transaction was originally expected to close on 31 August 2016, but GSK requested for additional time to enable both parties to comply with the terms of the Asset Purchase Agreement entered into on 31st March 2016.

Read More

GSK Consumer Nigeria declares N3.7bn net loss in half-year as currency devaluation bites

August 02, 2016   Editor   No comments

GlaxoSmithKline Consumer Nigeria Plc (“GSK Consumer Nigeria”) on Friday reported a net loss of N3.7bn for the first-half of 2016, down from N297m in the same period last year.

The company which recently sold its drinks business (Ribena and Lucozade brands) to Suntory Beverage & Foods Nigeria Limited so it can focus on healthcare and pharmaceuticals said that revenue for the period fell 9.6% to N13bn, down from N15bn last year.

Read More

GSK Nigeria dispels rumours of pending lay-offs after sale of beverage business

June 06, 2016   Editor   1 Comment

GlaxoSmithKline Consumer Nigeria Plc (GSK Nigeria) has put to rest fears of planned lay-offs post sale of its beverage business to Suntory.

Speaking to journalists in Lagos, GSK’s company Secretary, Mr. Uchenna Uwechia, said that the company’s Board of Directors has accepted Suntory Beverage & Food Limited offer to buy its beverage bottling and distribution business.

He noted that the Nigerian Stock Exchange (NSE) has been informed of its proposed plan to sell its beverage business as part of a post listing requirement of the exchange.

Read More

GSK Nigeria agrees to sell beverage unit to Suntory

June 01, 2016   Editor   No comments

GlaxoSmithKline Consumer Nigeria Plc (“GSK Nigeria”) said on Wednesday, it has accepted and is recommending to its shareholders, a binding offer from Suntory Beverage & Food Nigeria Ltd, a subsidiary of Suntory Beverage and Food Limited (“SBF”) of Japan, for the sale of its beverage unit, which includes bottling and distribution of Ribena, Lucozade and part of its Agbara plant.

Read More

GSK Consumer Nigeria posts 37% profit decline in the latest quarter

May 03, 2016   Editor   No comments

GlaxoSmithKline Consumer Nigeria Plc, the company behind beverage brands Lucozade and Ribena, among others, said on Thursday that its net income for the period January – March 31 2016 declined 37% to N188m, from N297m in the same quarter a year earlier.

Read More

GSK Consumer Nigeria gets dragged down by tough macro-economic environment, as profits decline 48.3% in Full Year

March 21, 2016   Editor   No comments

GlaxoSmithKline Consumer Nigeria Plc (GSK), makers of beverage brands – Ribena, Lucozade; and Wellness and Oral healthcare products has released its full year 2015 financials, showing a 48.3% net profit decline to N954m, from N1.84bn in the previous year.

Read More

GSK Nigeria posts higher results; shareholders applaud bonus dividend payout

June 17, 2015   Editor   No comments

GlaxoSmithkline Consumer Nigeria plc (GSK Nigeria) has announced a strong growth in its audited results for the year ended 31 December 2014, even as it approved bonus shares for its shareholders.

The company also declared a N717.5 million dividend for its shareholders for the year ended December 2014.

Speaking at the 44th Annual General Meeting (AGM) held in Lagos, Edmund Onuzo, Chairman GSK Nigeria Board of Directors stated that although the year 2014 was challenging, the company remains committed in ensuring shareholders get the best returns on their investments.

Read More

  • Archives